Reduction of the risk of acute tubular necrosis in ciclosporin-treated patients.
D058186:Acute Kidney Injury / Q000209:etiology* / Q000473:pathology; D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation; D007684:Kidney Tubules / Q000473:pathology; D007902:Length of Stay; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009336:Necrosis; D011183:Postoperative Complications; D006435:Renal Dialysis; D012306:Risk
D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine; D008775:Methylprednisolone